Literature DB >> 21873218

CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors.

Karen A O'Connell1, S Alireza Rabi, Robert F Siliciano, Joel N Blankson.   

Abstract

Elite suppressors/controllers (ES) are HIV-1-infected individuals who maintain stable CD4(+) T-cell counts and viral loads of <50 copies/mL without antiretroviral therapy. Research has predominantly focused on immune factors contributing to the control of viral replication in these patients. A more fundamental question, however, is whether there are differences in the nature of CD4(+) T-cell infection in ES compared with viremic patients. Here, we compare chronic progressor (CP), ES, and uninfected donors in terms of three aspects of CD4(+) T-cell infection: cellular susceptibility to infection, death of infected cells, and production of virus from infected cells. Using multiple methods of infection and both single-cycle and replication-competent virus, we show that unmanipulated CD4(+) T-cell populations from ES are actually more susceptible to HIV-1 infection than those populations from CP. Depletion of highly susceptible cells in CP may contribute to this difference. Using 7AAD and AnnexinV staining, we show that infected cells die more rapidly than uninfected cells, but the increased death of infected cells from CP and ES is proportional. Finally, using an assay for measuring virus production, we show that virus production by cells from CP is high compared with virus production by cells from ES or uninfected donors. This higher virus production is linked to cellular activation levels. These data identify fundamental differences in chronic infection of ES and CP that likely contribute to differential HIV-1 disease progression.

Entities:  

Mesh:

Year:  2011        PMID: 21873218      PMCID: PMC3174588          DOI: 10.1073/pnas.1108866108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  73 in total

1.  HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.

Authors:  Helene Mens; Mary Kearney; Ann Wiegand; Wei Shao; Kristian Schønning; Jan Gerstoft; Niels Obel; Frank Maldarelli; John W Mellors; Thomas Benfield; John M Coffin
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.

Authors:  Karen A O'Connell; Timothy P Brennan; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

3.  Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses.

Authors:  Asier Sáez-Cirión; So Youn Shin; Pierre Versmisse; Françoise Barré-Sinoussi; Gianfranco Pancino
Journal:  Nat Protoc       Date:  2010-05-13       Impact factor: 13.491

Review 4.  Elucidating the elite: mechanisms of control in HIV-1 infection.

Authors:  Karen A O'Connell; Justin R Bailey; Joel N Blankson
Journal:  Trends Pharmacol Sci       Date:  2009-12       Impact factor: 14.819

5.  Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV.

Authors:  Stephen A Migueles; Mark Connors
Journal:  JAMA       Date:  2010-07-14       Impact factor: 56.272

Review 6.  Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease.

Authors:  Pratip K Chattopadhyay; Mario Roederer
Journal:  Cytometry A       Date:  2010-07       Impact factor: 4.355

7.  Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.

Authors:  B Julg; F Pereyra; M J Buzón; A Piechocka-Trocha; M J Clark; B M Baker; J Lian; T Miura; J Martinez-Picado; M M Addo; B D Walker
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

8.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

9.  Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.

Authors:  Adam R Hersperger; Florencia Pereyra; Martha Nason; Korey Demers; Prameet Sheth; Lucy Y Shin; Colin M Kovacs; Benigno Rodriguez; Scott F Sieg; Leia Teixeira-Johnson; Debbie Gudonis; Paul A Goepfert; Michael M Lederman; Ian Frank; George Makedonas; Rupert Kaul; Bruce D Walker; Michael R Betts
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

10.  Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection.

Authors:  Annie Gosselin; Patricia Monteiro; Nicolas Chomont; Felipe Diaz-Griffero; Elias A Said; Simone Fonseca; Vanessa Wacleche; Mohamed El-Far; Mohamed-Rachid Boulassel; Jean-Pierre Routy; Rafick-Pierre Sekaly; Petronela Ancuta
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

View more
  26 in total

1.  Comprehensive analysis of unique cases with extraordinary control over HIV replication.

Authors:  Daniel Mendoza; Sarah A Johnson; Bennett A Peterson; Ven Natarajan; Maria Salgado; Robin L Dewar; Peter D Burbelo; Nicole A Doria-Rose; Erin H Graf; Jamieson H Greenwald; Jessica N Hodge; William L Thompson; Nancy A Cogliano; Cheryl L Chairez; Catherine A Rehm; Sara Jones; Claire W Hallahan; Joseph A Kovacs; Irini Sereti; Omar Sued; Sheila A Peel; Robert J O'Connell; Una O'Doherty; Tae-Wook Chun; Mark Connors; Stephen A Migueles
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

2.  HIV-1 Virion Production from Single Inducible Proviruses following T-Cell Activation Ex Vivo.

Authors:  John K Bui; John W Mellors; Anthony R Cillo
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

Review 3.  Unravelling the mechanisms of durable control of HIV-1.

Authors:  Bruce D Walker; Xu G Yu
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

4.  Inhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressors.

Authors:  Robert W Buckheit; Maria Salgado; Robert F Silciano; Joel N Blankson
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

5.  Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.

Authors:  Wendy E Walker; Sebastian Kurscheid; Samit Joshi; Charlie A Lopez; Gerald Goh; Murim Choi; Lydia Barakat; John Francis; Ann Fisher; Michael Kozal; Heidi Zapata; Albert Shaw; Richard Lifton; Richard E Sutton; Erol Fikrig
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

6.  Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.

Authors:  Shayarana L Gooneratne; Hamid Alinejad-Rokny; Diako Ebrahimi; Patrick S Bohn; Roger W Wiseman; David H O'Connor; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

7.  A rapid label-free method for quantitation of human immunodeficiency virus type-1 particles by nanospectroscopy.

Authors:  Olivia Block; Anirban Mitra; Lukas Novotny; Carrie Dykes
Journal:  J Virol Methods       Date:  2012-03-20       Impact factor: 2.014

Review 8.  The implications of viral reservoirs on the elite control of HIV-1 infection.

Authors:  Robert W Buckheit; Maria Salgado; Karen O Martins; Joel N Blankson
Journal:  Cell Mol Life Sci       Date:  2012-08-04       Impact factor: 9.261

9.  Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression.

Authors:  Evan S Jacobs; Sheila M Keating; Mohamed Abdel-Mohsen; Stuart L Gibb; John W Heitman; Heather C Inglis; Jeffrey N Martin; Jinbing Zhang; Zhanna Kaidarova; Xutao Deng; Shiquan Wu; Kathryn Anastos; Howard Crystal; Maria C Villacres; Mary Young; Ruth M Greenblatt; Alan L Landay; Stephen J Gange; Steven G Deeks; Elizabeth T Golub; Satish K Pillai; Philip J Norris
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

10.  Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro.

Authors:  Maame Efua S Sampah; Gregory M Laird; Joel N Blankson; Robert F Siliciano; Jenell S Coleman
Journal:  AIDS       Date:  2015-06-19       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.